New drug trial aims to protect failing kidneys
Disease control
Recruiting now
This study is testing an experimental drug called WAL0921 in people with specific kidney diseases that cause protein to leak into the urine. Participants will receive either the drug or a placebo via an IV infusion every two weeks for about three months. The main goals are to see…
Phase: PHASE2 • Sponsor: Walden Biosciences • Aim: Disease control
Last updated Apr 02, 2026 05:26 UTC